Profile
Al Blunt worked as Vice President-Medical at Advaxis, Inc. from 2017 to 2018.
He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from City College.
Former positions of Al Blunt
| Companies | Position | End |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-09-30 |
Training of Al Blunt
| University of Pennsylvania | Doctorate Degree |
| City College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Al Blunt
